Annual Total Debt
$7.61 B
+$1.48 B+24.08%
December 31, 2024
Summary
- As of March 13, 2025, RPRX annual total debt is $7.61 billion, with the most recent change of +$1.48 billion (+24.08%) on December 31, 2024.
- During the last 3 years, RPRX annual total debt has risen by +$516.36 million (+7.28%).
- RPRX annual total debt is now at all-time high.
Performance
RPRX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$7.61 B
+$5.05 M+0.07%
December 31, 2024
Summary
- As of March 13, 2025, RPRX quarterly total debt is $7.61 billion, with the most recent change of +$5.05 million (+0.07%) on December 31, 2024.
- Over the past year, RPRX quarterly total debt has increased by +$1.48 billion (+24.08%).
- RPRX quarterly total debt is now at all-time high.
Performance
RPRX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
RPRX Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +24.1% | +24.1% |
| 3 y3 years | +7.3% | +24.1% |
| 5 y5 years | +22.0% | +24.1% |
RPRX Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +24.1% | at high | +24.2% |
| 5 y | 5-year | at high | +30.9% | at high | +31.0% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Royalty Pharma Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $7.61 B(+24.1%) | $7.61 B(+0.1%) |
| Sep 2024 | - | $7.61 B(+0.1%) |
| Jun 2024 | - | $7.60 B(+23.8%) |
| Mar 2024 | - | $6.14 B(+0.1%) |
| Dec 2023 | $6.14 B(-13.8%) | $6.14 B(+0.1%) |
| Sep 2023 | - | $6.13 B(-14.0%) |
| Jun 2023 | - | $7.13 B(+0.1%) |
| Mar 2023 | - | $7.12 B(+0.1%) |
| Dec 2022 | $7.12 B(+0.3%) | $7.12 B(+0.1%) |
| Sep 2022 | - | $7.11 B(+0.1%) |
| Jun 2022 | - | $7.11 B(+0.1%) |
| Mar 2022 | - | $7.10 B(+0.1%) |
| Dec 2021 | $7.10 B | $7.10 B(+0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $7.09 B(+21.7%) |
| Jun 2021 | - | $5.83 B(+0.1%) |
| Mar 2021 | - | $5.82 B(+0.1%) |
| Dec 2020 | $5.82 B(-6.8%) | $5.82 B(+0.1%) |
| Sep 2020 | - | $5.81 B(-1.7%) |
| Jun 2020 | - | $5.91 B(-0.8%) |
| Mar 2020 | - | $5.96 B(-4.5%) |
| Dec 2019 | $6.24 B(-4.3%) | $6.24 B(>+9900.0%) |
| Sep 2019 | - | $0.00(0.0%) |
| Jun 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00 |
| Dec 2018 | $6.52 B(>+9900.0%) | - |
| Dec 2017 | $0.00 | - |
FAQ
- What is Royalty Pharma annual total debt?
- What is the all time high annual total debt for Royalty Pharma?
- What is Royalty Pharma annual total debt year-on-year change?
- What is Royalty Pharma quarterly total debt?
- What is the all time high quarterly total debt for Royalty Pharma?
- What is Royalty Pharma quarterly total debt year-on-year change?
What is Royalty Pharma annual total debt?
The current annual total debt of RPRX is $7.61 B
What is the all time high annual total debt for Royalty Pharma?
Royalty Pharma all-time high annual total debt is $7.61 B
What is Royalty Pharma annual total debt year-on-year change?
Over the past year, RPRX annual total debt has changed by +$1.48 B (+24.08%)
What is Royalty Pharma quarterly total debt?
The current quarterly total debt of RPRX is $7.61 B
What is the all time high quarterly total debt for Royalty Pharma?
Royalty Pharma all-time high quarterly total debt is $7.61 B
What is Royalty Pharma quarterly total debt year-on-year change?
Over the past year, RPRX quarterly total debt has changed by +$1.48 B (+24.08%)